Skip to main content

Table 1 Demographic and clinical data

From: Morbidity and mortality related to pneumonia and TRACHEOBRONCHITIS in ICU after lung transplantation

Variable Total population (n = 175) Patients without BRI (n = 14) Patients with BRI (n = 161) *p patients with pneumonia (n = 34) Patients with tracheobronchitis without any episode of pneumonia (n = 127) *p
Age, year, median [IQR] 57 [50–60] 60 [55–63] 57 [50–60] 0.016 56 [50–59] 57 [49–60] 0.84
Male gender, n (%) 118 (67) 6 (42) 112 (69) 0.07 24 (71) 88 (69) 1
Underlying lung disease, n (%)
 Emphysema/COPD 70 (40) 5 (36) 65 (40) 0.78 14 (41) 51 (40) 1
 Idiopathic pulmonary fibrosis 66 (38) 7(50) 59 (37) 0.39 9 (27) 50 (39) 0.23
 Other 39 (22) 2 (14) 37 (23) 0.74 11 (32) 26 (21) 0.17
Transplantation type, n (%)
 Single lung 125 (71) 13 (92) 112 (69) 0.07 20 (59) 92 (72) 0.4
 Double 50 (29) 1 (8) 49 (31) 0.1 14 (41) 35 (28) 0.14
 SAPS II, median [IQR] 35 [29–42] 32 [28–36] 35 [29–42] 0.34 37 [32–48] 35 [28–42] 0.09
 SOFA 5 [3–8] 4 [3–6] 5 [3–8] 0.41 7 [4–10] 5 [3–7] 0.06
 ECLS, n (%) 30 (17) 2 (14) 28 (17) 0.76 12 (35) 16 (13) 0.004
 Primary graft dysfunction, n (%) 12 (7) 1 (7) 11 (7) 0.96 2 (6) 9 (7) 0.06
 Donor colonization prior to LT, n (%) 47 (42) 3 (21) 44 (27) 0.76 9 (47) 35 (42) 0.8
 One micro-organism 39 (83) 2 (67) 37 (84) 0.4 8 (89) 29 (83) 1
 More than one micro-organism 8 (17) 1 (33 7 (16) 0.4 1 (11) 6 (17) 1
 Recipient colonization prior to LT, n (%) 55 (38) 8 (61) 47 (36) 0.08 10 (34) 37 (36) 1
 One micro-organism 35 (64) 6 (75) 29 (62) 0.7 6 (60) 23 (62) 1
 More than one micro-organism 20 (36) 2 (25) 18 (38) 0.7 4 (40) 14 (38) 1
  1. A *p < 0.05 was considered statistically significant. LT = lung transplantation; COPD = Chronic obstructive pulmonary disease; ECLS = extracorporeal lung support; MV = mechanical ventilation; SOFA = Sequential Organ Failure Assessment; SAPSII = Simplified Acute Physiology Score